Bernardo Luis Sabatini

Bernardo Luis Sabatini

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Bernardo Luis Sabatini

Howard Hughes Medical Institute, Department of Neurobiology, Harvard Medical School, Boston MA, 02115, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2003 in BioMedical Engineering OnLine
Verified
Journal Article
Open access
PDF file
TPThomas A Pologruto
Thomas A Pologruto
BSBernardo L Sabatini
Bernardo L Sabatini
KSKarel Svoboda
Karel Svoboda
Laser scanning microscopy is a powerful tool for analyzing the structure and function of biological specimens. Although numerous commercial laser scanning microscopes exist, some of the more interesting and challenging applications demand custom design. A major impediment to custom design is the difficulty of building custom data acquisition hardware and writing the complex software required to run the laser scanning microscope. We describe a simple, software-based approach to operating a laser scanning microscope without the need for custom data acquisition hardware. Data acquisition and control of laser scanning are achieved through standard data acquisition boards. The entire burden of signal integration and image processing is placed on the CPU of the computer. We quantitate the effectiveness of our data acquisition and signal conditioning algorithm under a variety of conditions. We implement our approach in an open source software package (ScanImage) and describe its functionality. We present ScanImage, software to run a flexible laser scanning microscope that allows easy custom design.

14 March 2007 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GSGanesh M. Shankar
Ganesh M. Shankar
BBBrenda L. Bloodgood
Brenda L. Bloodgood
MTMatthew Townsend
Matthew Townsend
DWDominic M. Walsh
Dominic M. Walsh
DSDennis J. Selkoe
Dennis J. Selkoe
BSBernardo L. Sabatini
Bernardo L. Sabatini
Alzheimer's disease (AD) is characterized by decreased synapse density in hippocampus and neocortex, and synapse loss is the strongest anatomical correlate of the degree of clinical impairment. Although considerable evidence supports a causal role for the amyloid-β protein (Aβ) in AD, a direct link between a specific form of Aβ and synapse loss has not been established. We demonstrate that physiological concentrations of naturally secreted Aβ dimers and trimers, but not monomers, induce progressive loss of hippocampal synapses. Pyramidal neurons in rat organotypic slices had markedly decreased density of dendritic spines and numbers of electrophysiologically active synapses after exposure to picomolar levels of soluble oligomers. Spine loss was reversible and was prevented by Aβ-specific antibodies or a small-molecule modulator of Aβ aggregation. Mechanistically, Aβ-mediated spine loss required activity of NMDA-type glutamate receptors (NMDARs) and occurred through a pathway involving cofilin and calcineurin. Furthermore, NMDAR-mediated calcium influx into active spines was reduced by Aβ oligomers. Partial blockade of NMDARs by pharmacological antagonists was sufficient to trigger spine loss. We conclude that soluble, low-noligomers of human Aβ trigger synapse loss that can be reversed by therapeutic agents. Our approach provides a quantitative cellular model for elucidating the molecular basis of Aβ-induced neuronal dysfunction.

22 February 2018 in eLife
Verified
Journal Article
Open access
PZPengcheng Zhou
Pengcheng Zhou
SRShanna L Resendez
Shanna L Resendez
JRJose Rodriguez-Romaguera
Jose Rodriguez-Romaguera
JJJessica C Jimenez
Jessica C Jimenez
SNShay Q Neufeld
Shay Q Neufeld
LPLiam Paninski
Liam Paninski
In vivo calcium imaging through microendoscopic lenses enables imaging of previously inaccessible neuronal populations deep within the brains of freely moving animals. However, it is computationally challenging to extract single-neuronal activity from microendoscopic data, because of the very large background fluctuations and high spatial overlaps intrinsic to this recording modality. Here, we describe a new constrained matrix factorization approach to accurately separate the background and then demix and denoise the neuronal signals of interest. We compared the proposed method against previous independent components analysis and constrained nonnegative matrix factorization approaches. On both simulated and experimental data recorded from mice, our method substantially improved the quality of extracted cellular signals and detected more well-isolated neural signals, especially in noisy data regimes. These advances can in turn significantly enhance the statistical power of downstream analyses, and ultimately improve scientific conclusions derived from microendoscopic data.

1 October 2012 in Neuron
Verified
Journal Article
Closed access
NTNicolas X. Tritsch
Nicolas X. Tritsch
BSBernardo L. Sabatini
Bernardo L. Sabatini

3 October 2012 in Nature
Verified
Journal Article
Open access
PDF file
NTNicolas X. Tritsch
Nicolas X. Tritsch
JDJun B. Ding
Jun B. Ding
BSBernardo L. Sabatini
Bernardo L. Sabatini
Activation of midbrain dopamine neurons rapidly inhibits action potential firing in both direct- and indirect-pathway striatal projection neurons through VMAT2-dependent vesicular release of the inhibitory transmitter GABA (γ-aminobutyric acid). The striatum sits at a crossroads for a variety of brain inputs, including those from the cortex, hippocampus and midbrain. Large populations of dopaminergic neurons in the basal ganglia project to the striatum; recent genetic tools have made it possible to isolate these neurons and control them with light exposure using optogenetic techniques. Here, Bernardo Sabatini and colleagues report an unexpected function for these dopaminergic neurons in inhibiting striatal output. They find that the fast-acting neurotransmitter GABA is the source of this inhibition. Interestingly, GABA was not loaded into vesicles through the usual route, but through the VMAT2 transporter that also transfers dopamine. These findings extend the dynamics of dopaminergic neuron signalling and represent an example of co-transmission in these populations of cells. The substantia nigra pars compacta and ventral tegmental area contain the two largest populations of dopamine-releasing neurons in the mammalian brain. These neurons extend elaborate projections in the striatum, a large subcortical structure implicated in motor planning and reward-based learning. Phasic activation of dopaminergic neurons in response to salient or reward-predicting stimuli is thought to modulate striatal output through the release of dopamine to promote and reinforce motor action1,2,3,4. Here we show that activation of dopamine neurons in striatal slices rapidly inhibits action potential firing in both direct- and indirect-pathway striatal projection neurons through vesicular release of the inhibitory transmitter GABA (γ-aminobutyric acid). GABA is released directly from dopaminergic axons but in a manner that is independent of the vesicular GABA transporter VGAT. Instead, GABA release requires activity of the vesicular monoamine transporter VMAT2, which is the vesicular transporter for dopamine. Furthermore, VMAT2 expression in GABAergic neurons lacking VGAT is sufficient to sustain GABA release. Thus, these findings expand the repertoire of synaptic mechanisms used by dopamine neurons to influence basal ganglia circuits, show a new substrate whose transport is dependent on VMAT2 and demonstrate that GABA can function as a bona fide co-transmitter in monoaminergic neurons.

11 December 2017 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
SHSinisa Hrvatin
Sinisa Hrvatin
DHDaniel R. Hochbaum
Daniel R. Hochbaum
MNM. Aurel Nagy
M. Aurel Nagy
MCMarcelo Cicconet
Marcelo Cicconet
KRKeiramarie Robertson
Keiramarie Robertson
MGMichael E. Greenberg
Michael E. Greenberg